- Home
- TKLF vs RANI Comparison
TKLF vs RANI Comparison
Compare TKLF & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TKLF
- RANI
- Stock Information
- Founded
- TKLF 2006
- RANI 2012
- Country
- TKLF Japan
- RANI United States
- Employees
- TKLF N/A
- RANI N/A
- Industry
- TKLF Other Specialty Stores
- RANI Medicinal Chemicals and Botanical Products
- Sector
- TKLF Consumer Discretionary
- RANI Health Care
- Exchange
- TKLF Nasdaq
- RANI Nasdaq
- Market Cap
- TKLF 16.0M
- RANI 17.0M
- IPO Year
- TKLF 2022
- RANI 2021
- Fundamental
- Price
- TKLF N/A
- RANI $0.54
- Analyst Decision
- TKLF
- RANI Strong Buy
- Analyst Count
- TKLF 0
- RANI 4
- Target Price
- TKLF N/A
- RANI $7.75
- AVG Volume (30 Days)
- TKLF 9.6K
- RANI 323.8K
- Earning Date
- TKLF 07-10-2025
- RANI 08-05-2025
- Dividend Yield
- TKLF N/A
- RANI N/A
- EPS Growth
- TKLF N/A
- RANI N/A
- EPS
- TKLF 1.70
- RANI N/A
- Revenue
- TKLF $219,520,631.00
- RANI $1,200,000.00
- Revenue This Year
- TKLF N/A
- RANI N/A
- Revenue Next Year
- TKLF N/A
- RANI N/A
- P/E Ratio
- TKLF $2.19
- RANI N/A
- Revenue Growth
- TKLF 32.02
- RANI N/A
- 52 Week Low
- TKLF $2.20
- RANI $0.46
- 52 Week High
- TKLF $8.53
- RANI $4.19
- Technical
- Relative Strength Index (RSI)
- TKLF 52.23
- RANI 42.19
- Support Level
- TKLF $3.69
- RANI $0.50
- Resistance Level
- TKLF $3.95
- RANI $0.60
- Average True Range (ATR)
- TKLF 0.18
- RANI 0.03
- MACD
- TKLF 0.01
- RANI 0.02
- Stochastic Oscillator
- TKLF 70.67
- RANI 42.04
About TKLF Yoshitsu Co. Ltd
Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores; Online Stores and Services; and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from China followed by Japan and other overseas markets.
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.